General discussion re fundamentals, page-7

It may be, but with the FDA labelling it breakthrough technology i'm sure they will work with the company to get it through soon. For me, this is the biggest catalyst for this stock and with the current information we have I believe there is a high probability that it will be approved.

I believe it is business as usual and there is nothing material or relevant to report on until the EUA is finalised. Otherwise something would have been reported in accordance with the ASX rules. I am happy to wait.

Perhaps you can use the cheap share price to your advantage.

IMO GLTAH